MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 364 filers reported holding MEDIVATION INC in Q1 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,087,000 | +275.5% | 100,939 | +186.3% | 0.01% | +250.0% |
| Q1 2016 | $1,621,000 | -12.1% | 35,262 | -7.5% | 0.00% | 0.0% |
| Q4 2015 | $1,844,000 | +22.9% | 38,138 | +8.0% | 0.00% | 0.0% |
| Q3 2015 | $1,500,000 | -23.3% | 35,302 | +106.2% | 0.00% | 0.0% |
| Q2 2015 | $1,955,000 | +3.6% | 17,118 | +17.1% | 0.00% | 0.0% |
| Q1 2015 | $1,887,000 | +20.3% | 14,614 | -7.2% | 0.00% | 0.0% |
| Q4 2014 | $1,568,000 | -78.1% | 15,745 | -78.3% | 0.00% | -75.0% |
| Q3 2014 | $7,160,000 | +937.7% | 72,415 | +709.1% | 0.01% | +700.0% |
| Q2 2014 | $690,000 | +19.8% | 8,950 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $576,000 | +4.3% | 8,950 | +3.4% | 0.00% | 0.0% |
| Q4 2013 | $552,000 | -70.9% | 8,655 | -72.7% | 0.00% | -66.7% |
| Q3 2013 | $1,898,000 | +39.5% | 31,659 | +14.5% | 0.00% | +50.0% |
| Q2 2013 | $1,361,000 | – | 27,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |